All treatments
Treatment
Bone marrow aspirate clinical trials
2 indexed studies · 1 currently recruiting
- Recruiting
Precision Medicine for Stem Cell Transplantation
This study looks at new blood tests for people having stem cell transplants. It aims to predict serious problems like graft-versus-host disease and cancer coming back. The goal is to help doctors give better, more tailored care and improve treatment success.
For: Haematopoietic Stem Cell TransplantationUnited Kingdom - Active not recruitingPHASE2
Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone
This study is testing different combinations of new drugs (olaparib, durvalumab, capivasertib, and cediranib) for recurrent or hard-to-treat womb cancer. The aim is to find out if these combinations can stop the cancer from growing or spreading more effectively.
For: Endometrial Adenocarcinoma · Endometrial Mixed Cell Adenocarcinoma · Endometrial Serous AdenocarcinomaUnited States · Canada